Financial Performance: Oriental Aromatics reported consolidated operating revenue of Rs. 223 crore for the quarter, reflecting a 13% year-over-year increase. EBITDA was Rs. 23 crore, growing 60% year-over-year, with an EBITDA margin of 10.15%, up 301 basis points from the previous year. Net profit reached Rs. 7 crore, an impressive increase of 174% with a PAT margin of 3.19%. For the nine months of FY ’25, operating revenue totaled Rs. 675 crore, up 9% year-on-year, while EBITDA was Rs. 73 crore, up over 181%. The net profit turned positive at Rs. 33 crore, demonstrating effective efficiency measures.
Future Outlook and Growth Drivers: Management expressed confidence in long-term goals, despite seasonal headwinds and macroeconomic pressures. The Fragrance & Flavor division is experiencing double-digit growth, supported by new customer acquisition and innovative product offerings. The company aims for continued market leadership, aligning with evolving consumer trends, especially in fine fragrances.
Order Book and Operational Updates: The company remains committed to expanding its product portfolio and operational efficiencies. Although facing market challenges in the camphor segment, demand for terpene-based products is robust, indicating potential for improved profitability.
Analyst Q&A Insights: Key concerns included future volume growth projections, pricing trends, and the impact of recent capital expenditures on depreciation and finance costs. Management reassured analysts about stable future volumes across segments and highlighted their focus on achieving optimal utilization of recently commissioned plants.
Market or Regulatory Updates: The company has successfully retained U.S. FDA certification for camphor, ensuring adherence to quality standards.
Strategic Focus Areas: Emphasis on innovation, sustainability, and expanding competitive positioning is evident, with management aiming to optimize margins across all divisions.
Investor Insight: Given solid financial performance and management’s strategic outlook, the company appears well-positioned for growth. The trajectory aligns with a 'buy' position, considering both current resilience and long-term potential challenges ahead.